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Abstract The peripheral membrane protein gephyrin is essen-
tial for the postsynaptic localization of the inhibitory glycine
receptor and is thought to anchor the receptor complex to the
subsynaptic cytoskeleton. Since gephyrin transcripts are also
found in non-neuronal tissues, we analyzed the 5P-flanking region
of the gephyrin gene to identify its promoter region. This region
contains several SP1 consensus sites, which may account for the
widespread expression of gephyrin mRNA. Indeed, reporter gene
constructs encompassing at least the two SP1 consensus sites
upstream from the transcription start site were efficiently
transcribed in both a fibroblast and a neuronal cell line. Our
data are consistent with the widespread expression of the
gephyrin gene in most mammalian tissues.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Gephyrin was originally identi¢ed as a peripheral mem-
brane protein of relative molecular mass 93 kDa that co-pu-
ri¢es with the mammalian inhibitory glycine receptor upon
a¤nity chromatography [1^3]. Light and electron microscopic
immunocytochemistry revealed that gephyrin decorates the
cytoplasmic face of glycinergic and a subset of GABAergic
postsynaptic membrane specializations in spinal cord and
brain [4^8]. In cultured spinal neurons, the accumulation of
gephyrin at developing postsynaptic sites precedes the synap-
tic clustering of the glycine receptor [9,10], and inhibition of
gephyrin expression by antisense oligonucleotides prevents the
formation of glycine receptor clusters in these cultures [9].
Gephyrin expression is therefore considered essential for the
synaptic localization of the glycine receptor [9]. Interestingly,
transcription of the gephyrin gene is not restricted to the
central nervous system, since gephyrin transcripts were also
found in liver, kidney, heart, and possibly lung [11]. We there-
fore characterized the putative promoter region of the murine
gephyrin gene and found a 5P-£anking region harbouring mul-
tiple transcription factor binding sites suitable for driving
strong and ubiquitous expression of the gephyrin gene. Our
data demonstrate a high transcriptional activity of the prox-
imal portion of the promoter region in both a neuronal and a
non-neuronal cell line.
2. Materials and methods
2.1. Library screening
A mouse brain cDNA library constructed in the phage vector V-
ZAPII (Stratagene, Heidelberg, Germany) was used to isolate a full
length mouse gephyrin cDNA according to standard procedures [12].
P1 clones harbouring the 5P untranslated region (UTR) of the gephyr-
in gene were identi¢ed by PCR screening of a P1 library (Genome
Systems Inc., St. Louis, USA) using oligonucleotide primers derived
from genomic sequences upstream from the translation start site.
2.2. Chemicals and enzymes
Radiochemicals used for radiolabelling of DNA probes were pur-
chased from Amersham (Braunschweig, Germany), and DNA-modi-
fying enzymes and restriction endonucleases from Boehringer (Mann-
heim, Germany). Fine chemicals were obtained from Sigma
(Deisenhofen, Germany).
2.3. RNA preparation and primer extension
Total RNA was prepared from mouse brain extracts by guanidine/
caesium chloride extraction [13]. 50 Wg of total RNA were used for
primer extension with an oligonucleotide of 29 bases, antisense to
positions +167 to +139 of the 5P UTR of the p1 cDNA [11], and
`SuperScript' reverse transcriptase (Gibco, Eggenstein, Germany) ac-
cording to standard protocols [14]. To prevent mismatch priming,
annealing and extension were performed at 53³C.
2.4. Reporter gene constructs
Fragments of the 5P-£anking region were ¢rst subcloned into pBlue-
script SK+ and subsequently transferred into the HindIII/BglII sites
of the luciferase vector pGL
2
(Promega, Heidelberg, Germany), tak-
ing advantage of the SmaI site at position +141 downstream from the
transcription start point. Construct LUP2 was created by subcloning
a 1.7 kb EcoRI/SmaI fragment of the 5P-£anking region, and the
construct LUP1 was derived from a shorter PstI/SmaI fragment of
the same region corresponding to positions 3534 to +140. Constructs
LUP1c and LUP1d were generated taking advantage of a BssHII site
at position 3234 and an NaeI site at position 3159 for subcloning.
The smaller fragments for constructs LUP1f and LUP1g were created
by subcloning PCR-ampli¢ed fragments covering positions 374 to
+140 and positions 323 to +140. Negative numbers correspond to
bp upstream of the transcription start site.
2.5. DNA transfections and luciferase assays
Human 293 embryonic kidney (HEK 293; ATCC no. CRL1537)
cells were cultured at 37³C in a humidi¢ed atmosphere of 95% air/5%
CO
2
in Minimal Essential Medium (Gibco, Eggenstein, Germany),
and N18 neuroblastoma (N18TG2; ATCC no. DSM ACC103) cells
were maintained in an atmosphere of 90% air/10% CO
2
in Dulbecco's
Minimal Essential Medium (Gibco, Eggenstein, Germany). Both cul-
ture media were supplemented with 50 U penicillin/ml, 50 Wg/ml strep-
tomycin (Flow Laboratories), 2 mM L-glutamine (Boehringer) and
10% (v/v) fetal calf serum (Gibco, Eggenstein, Germany). Cells were
grown to 80% con£uency and subsequently transfected using the Ca
2
phosphate precipitation method [15] followed by a glycerol shock
after 5 h [16]. To assess the e¤ciency of the transfections, cells were
co-transfected with equal amounts of a pSV40 L-galactosidase vector
(Promega, Heidelberg, Germany). 2 days after transfection, the cells
were washed with phosphate-bu¡ered saline and lysed in 150 Wl of
1UReporter Lysis bu¡er (Promega, Heidelberg, Germany). Aliquots
(20 Wl) of the lysate were assayed for luciferase activity in a Lumat
luminometer (Berthold, Bad Wildbad, Germany). The e¤ciency of
each transfection was determined by a colorimetric L-galactosidase
assay according to the manufacturer's instructions (Promega, Heidel-
berg, Germany). The luciferase activity was determined from three
individual culture dishes. To test the e¡ect of metal ions on promoter
activity, we added 50 WM ZnCl
2
, 250 WM CuSO
4
, or 2.5 WM CdCl
2
to
the culture medium immediately after the glycerol shock and there-
after determined luciferase activities as described above.
2.6. DNA sequencing
Nucleotide sequences were determined according to the dideoxy
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chain termination method using either a T
7
-sequencing kit (Pharma-
cia, Freiburg, Germany) or a DyeDeoxy Terminator Cycle sequencing
kit (Applied Biosystems Inc., Langen, Germany) according to the
manufacturer's instructions. Sequence-speci¢c primers were synthe-
sized using a Gene Assembler Plus (Pharmacia, Freiburg, Germany).
All sequences were con¢rmed by analyzing both DNA strands.
3. Results
3.1. Identi¢cation of the transcription start site
In order to determine the transcription start site of the
murine gephyrin mRNA, we performed primer extension ex-
periments with antisense primers derived from di¡erent re-
gions of the 5P UTR. These experiments unequivocally located
the transcription start point 401 bp upstream from the start
codon (Fig. 1).
3.2. Characterization of the 5P-£anking region of the gephyrin
gene
The 5P-£anking region was analyzed further by sequencing
about 1 kb of genomic DNA upstream from the start codon.
Comparison with the mouse cDNA isolated from a brain
cDNA library (see Section 2) indicated no additional introns
within this region of the 5P UTR. GC-rich regions with 5 con-
sensus sites for SP1 [17,18] and a CCAAT box like element
[19] were identi¢ed at positions 255^260, 186^190, 172^177,
32^37, and 13^19, respectively, and between positions 178 and
182 bp upstream from the transcription start point (Fig. 2). In
addition, we found consensus binding sites for the transcrip-
tion factors AP-2 [20] (positions 391 to 380 and 3260 to
3251), PEA3 [21] (positions 3443 to 3438) and the muscle-
speci¢c transcription factor MyoD [22] (positions 3331 to
3336). Consensus sites for metal response elements MBF-1
CS and MRE CS [23,24] were found at positions 3208 to
3202 and 359 to 356 bp, respectively (Fig. 2). However,
no consensus sites for neuron-speci¢c transcription factors
could be identi¢ed in this region of the gephyrin gene.
3.3. Transcriptional activity of the 5P-£anking region
To demonstrate that the 5P-£anking region contains a func-
tional gephyrin promoter, we chose a DNA fragment (LUP1)
encompassing positions 3534 to +140 to drive luciferase ex-
pression in ¢broblasts (HEK 293) and neuroblastoma (N18)
cells. This construct produced 4^5-fold higher expression of
the reporter gene than the SV40 promoter in both cell lines
(Fig. 3). A second construct (LUP2), which extended approx.
1.7 kb further upstream, did not exhibit signi¢cantly higher
activity. We therefore conclude that relevant regulatory ele-
ments of gephyrin gene expression are located within a region
of the 5P-£anking sequence extending 534 bp upstream from
the transcription start point. In order to further delineate sites
important for promoter activity, we generated several deletion
constructs. Construct LUP1c lacking the most 5P SP1 consen-
sus site and the consensus sites for PEA3 and MyoD gave
decreased luciferase expression as compared to LUP1 or
LUP2 (Fig. 3). Deletion of two additional downstream SP1
sites, two AP-2 sites, the CCAAT box, and one metal re-
sponse element in construct LUP1d decreased the luciferase
activity by another approx. 30% in HEK 293, but not in N18
neuroblastoma cells. The shortest construct (LUP1g) starting
23 bp upstream from the transcription start point and har-
bouring a single SP1 site showed no signi¢cant expression, but
a construct only 51 bp longer, and therefore carrying a second
SP1 site and a metal response element (LUP1f), allowed the
expression of the reporter gene at levels higher than those
obtained with the SV40 promoter containing control plasmid
(Fig. 3). Since two consensus sites for metal response elements
were found in the 5P-£anking region, we also investigated the
e¡ect of di- and tri-valent metal ions on promoter activity.
Treatment of transfected cells with Zn
2
, Cu
3
or Cd
2
ions
did not lead to signi¢cant changes in L-galactosidase activity
(not shown). Notably, the expression levels observed with the
di¡erent constructs were similar in both cell lines, suggesting a
lack of cell type speci¢city of the gephyrin promoter. We
conclude from these data that the SP1 sites are important
determinants of gephyrin promoter activity.
4. Discussion
We have analyzed the 5P-£anking region of the gephyrin
gene and located the transcription start point 401 bp upstream
of the start codon of the gephyrin cDNA. Comparison of the
transcriptional activities of sequences extending 1.7 kb and
534 bp upstream from the transcription start point clearly
showed that the shorter construct contained important pro-
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Fig. 1. Determination of the transcription start point. (Left) Autora-
diograph of the
35
S-labelled gephyrin reference sequence primed
with the same oligonucleotide as used for primer extension. Nucleo-
tides are indicated at the bottom. (Right) Electrophoretic separation
of the primer extension reaction (PE). Only a single band is de-
tected, which indicates a transcription start point at position 3401.
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moter elements of the gephyrin gene. Computational analysis
of this region revealed several consensus sites for transcription
factors including ¢ve consensus sites for SP1 binding, two AP-
2 consensus sites, two consensus sites for metal response ele-
ments, one CCAAT box like element, and one PEA3 and one
MyoD consensus site, each. Our reporter construct assays
show that the 5P UTR of the gephyrin gene contains a highly
e¤cient promoter region and that the proximal SP1 consensus
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Fig. 3. Structure and activity of gephyrin promoter driven reporter gene constructs. (A) Schematic representation of the fragments from the 5P
upstream region of the gephyrin gene used for reporter plasmid construction. Consensus sites for transcription factor binding, promoter ele-
ments and the transcription start point (arrow) are indicated above the LUP2 fragment. Lines represent the 5P segments used to construct addi-
tional plasmids for determining transcriptional activity by the luciferase assay. (B) The bars represent the luciferase activities obtained in
HEK293 (l) and N18 (E) cells transfected with a promoterless control plasmid (pGL2), a control plasmid containing the SV40 promoter
(SV40), and the reporter constructs indicated on the left. Activity values represent the meanþS.E.M. of three independent experiments as de-
tailed under Section 2.
Fig. 2. Sequence of the mouse gephyrin promoter region. About 1 kb of DNA upstream of the translation start site were sequenced (available
under GenBank/EMBL database accession numbers Y10882 and Y10883). The sequence of the 5P-£anking region used to generate promoter
constructs is shown. The 5P ends of the segments used in the reporter plasmids are indicated by horizontal arrows followed by the name of the
respective construct. The transcription start site (+1) is marked with an asterisk. Underlined sequences correspond to consensus binding motifs
for transcription factors; the position of a CCAAT box is also indicated.
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elements are particularly important for its activity. The tran-
scription factor SP1 is found in many di¡erent cell types and
organs [18] ; this may account for the widespread expression
of gephyrin transcripts in all rat tissues investigated [11].
The contribution of the other transcription factor binding
sites was not analyzed in detail due to their close overlap with
SP1 sites or the absence of the relevant transcription factors
(MyoD) in the cell lines used. Surprisingly, deletion of the
CCAAT box did not abolish transcription, as seen with pro-
moters from other genes [25^27]; a modulatory in£uence of
the CCAAT box on transcription rates, however, may have
escaped detection by our assay system. The presence of metal
response elements in the 5P UTR suggests a modulatory e¡ect
of metal ions on the transcriptional activity of the gephyrin
promoter. However, the addition of di- or tri-valent metal
ions, such as Zn
2
, Cu
3
, and Cd
2
, did not lead to signi¢cant
changes in reporter gene activity in the cell lines used.
Gephyrin transcripts have been demonstrated in a variety
of organs including in brain, liver, heart and lung [11]. These
¢ndings are substantiated here by structural and functional
features of the promoter region of the gephyrin gene. How-
ever, the physiological signi¢cance of the widespread expres-
sion of gephyrin outside the nervous system remains unclear.
One might speculate that the known homology of the N- and
C-terminal regions of the polypeptide to proteins involved in
the biosynthesis of the molybdenum cofactor [11,28,29] im-
plies a dual function. The targeted disruption of the gephyrin
gene should clarify whether gephyrin contributes to molybde-
num cofactor biosynthesis in addition to its role in anchoring
inhibitory neurotransmitter receptors.
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